Home › Steatotic Liver Disease › Texas › Garland
Steatotic Liver Disease clinical trials in Garland, TX
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Garland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- GI Alliance Digestive Health Associates of Texas - Garland, Garland
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Garland
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Medrasa Clinical Research, Wylie · 9 mi away
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- Miami, FL17 studies
- San Antonio, TX16 studies
- New York City, NY16 studies
- Houston, TX14 studies
- Austin, TX13 studies
- San Diego, CA12 studies
- Hialeah, FL11 studies
- Richmond, VA11 studies
- New Orleans, LA10 studies
- Orlando, FL10 studies
- Tucson, AZ10 studies
- Cape Coral, FL9 studies
Other studies in Garland
- Ulcerative Colitis8 studies
- Inflammatory Bowel Disease4 studies
- Crohn's Disease4 studies
- Obesity3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.